OTTO DAWN PARSELL (Sr VP, Clinical Development) reported 1 transaction at TRICIDA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/4/2022ACC: 0001595585-22-000004
Officer· Sr VP, Clinical Development
Since Aug 2018
-1.57K
Net shares
Net seller
$15.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.57K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.57K
Price / share
$9.56
Trade value
$15.05K
% of position
31.2%
12/31/2021
5.04K→3.46K
Total
Net shares
−1.57K
Net value
-$15.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2021 | F · Tax Withholding | −1.57K | $9.56 | $15.05K | 31.2% | 5.04K | 3.46K |
| Total | −1.57K | -$15.05K | ||||||
Derivative Transactions0
No derivative transactions reported